Cargando…

A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres

BACKGROUND: Total mesorectal excision has been the gold standard for the operative management of rectal cancer. The most frequently used minimally invasive techniques for surgical resection of rectal cancer are laparoscopic, robot-assisted, and transanal total mesorectal excision. As studies compari...

Descripción completa

Detalles Bibliográficos
Autores principales: Smalbroek, Bo, Geitenbeek, Ritchie, Burghgraef, Thijs, Dijksman, Lea, Hol, Jeroen, Rutgers, Marieke, Crolla, Rogier, van Geloven, Nanette, Leijtens, Jeroen, Polat, Fatih, Pronk, Apollo, Verdaasdonk, Emiel, Tuynman, Jurriaan, Sietses, Colin, Postma, Maarten, Hompes, Roel, Consten, Esther, Smits, Anke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431334/
https://www.ncbi.nlm.nih.gov/pubmed/37600875
http://dx.doi.org/10.1097/AS9.0000000000000263
_version_ 1785091176504754176
author Smalbroek, Bo
Geitenbeek, Ritchie
Burghgraef, Thijs
Dijksman, Lea
Hol, Jeroen
Rutgers, Marieke
Crolla, Rogier
van Geloven, Nanette
Leijtens, Jeroen
Polat, Fatih
Pronk, Apollo
Verdaasdonk, Emiel
Tuynman, Jurriaan
Sietses, Colin
Postma, Maarten
Hompes, Roel
Consten, Esther
Smits, Anke
author_facet Smalbroek, Bo
Geitenbeek, Ritchie
Burghgraef, Thijs
Dijksman, Lea
Hol, Jeroen
Rutgers, Marieke
Crolla, Rogier
van Geloven, Nanette
Leijtens, Jeroen
Polat, Fatih
Pronk, Apollo
Verdaasdonk, Emiel
Tuynman, Jurriaan
Sietses, Colin
Postma, Maarten
Hompes, Roel
Consten, Esther
Smits, Anke
author_sort Smalbroek, Bo
collection PubMed
description BACKGROUND: Total mesorectal excision has been the gold standard for the operative management of rectal cancer. The most frequently used minimally invasive techniques for surgical resection of rectal cancer are laparoscopic, robot-assisted, and transanal total mesorectal excision. As studies comparing the costs of the techniques are lacking, this study aims to provide a cost overview. METHOD: This retrospective cohort study included patients who underwent total mesorectal resection between 2015 and 2017 at 11 dedicated centers, which completed the learning curve of the specific technique. The primary outcome was total in-hospital costs of each technique up to 30 days after surgery including all major surgical cost drivers, while taking into account different team approaches in the transanal approach. Secondary outcomes were hospitalization and complication rates. Statistical analysis was performed using multivariable linear regression analysis. RESULTS: In total, 949 patients were included, consisting of 446 laparoscopic (47%), 306 (32%) robot-assisted, and 197 (21%) transanal total mesorectal excisions. Total costs were significantly higher for transanal and robot-assisted techniques compared to the laparoscopic technique, with median (interquartile range) for laparoscopic, robot-assisted, and transanal at €10,556 (8,642;13,829), €12,918 (11,196;16,223), and € 13,052 (11,330;16,358), respectively (P < 0.001). Also, the one-team transanal approach showed significant higher operation time and higher costs compared to the two-team approach. Length of stay and postoperative complications did not differ between groups. CONCLUSION: Transanal and robot-assisted approaches show higher costs during 30-day follow-up compared to laparoscopy with comparable short-term clinical outcomes. Two-team transanal approach is associated with lower total costs compared to the transanal one-team approach.
format Online
Article
Text
id pubmed-10431334
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer Health, Inc.
record_format MEDLINE/PubMed
spelling pubmed-104313342023-08-18 A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres Smalbroek, Bo Geitenbeek, Ritchie Burghgraef, Thijs Dijksman, Lea Hol, Jeroen Rutgers, Marieke Crolla, Rogier van Geloven, Nanette Leijtens, Jeroen Polat, Fatih Pronk, Apollo Verdaasdonk, Emiel Tuynman, Jurriaan Sietses, Colin Postma, Maarten Hompes, Roel Consten, Esther Smits, Anke Ann Surg Open Original Study BACKGROUND: Total mesorectal excision has been the gold standard for the operative management of rectal cancer. The most frequently used minimally invasive techniques for surgical resection of rectal cancer are laparoscopic, robot-assisted, and transanal total mesorectal excision. As studies comparing the costs of the techniques are lacking, this study aims to provide a cost overview. METHOD: This retrospective cohort study included patients who underwent total mesorectal resection between 2015 and 2017 at 11 dedicated centers, which completed the learning curve of the specific technique. The primary outcome was total in-hospital costs of each technique up to 30 days after surgery including all major surgical cost drivers, while taking into account different team approaches in the transanal approach. Secondary outcomes were hospitalization and complication rates. Statistical analysis was performed using multivariable linear regression analysis. RESULTS: In total, 949 patients were included, consisting of 446 laparoscopic (47%), 306 (32%) robot-assisted, and 197 (21%) transanal total mesorectal excisions. Total costs were significantly higher for transanal and robot-assisted techniques compared to the laparoscopic technique, with median (interquartile range) for laparoscopic, robot-assisted, and transanal at €10,556 (8,642;13,829), €12,918 (11,196;16,223), and € 13,052 (11,330;16,358), respectively (P < 0.001). Also, the one-team transanal approach showed significant higher operation time and higher costs compared to the two-team approach. Length of stay and postoperative complications did not differ between groups. CONCLUSION: Transanal and robot-assisted approaches show higher costs during 30-day follow-up compared to laparoscopy with comparable short-term clinical outcomes. Two-team transanal approach is associated with lower total costs compared to the transanal one-team approach. Wolters Kluwer Health, Inc. 2023-03-07 /pmc/articles/PMC10431334/ /pubmed/37600875 http://dx.doi.org/10.1097/AS9.0000000000000263 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Study
Smalbroek, Bo
Geitenbeek, Ritchie
Burghgraef, Thijs
Dijksman, Lea
Hol, Jeroen
Rutgers, Marieke
Crolla, Rogier
van Geloven, Nanette
Leijtens, Jeroen
Polat, Fatih
Pronk, Apollo
Verdaasdonk, Emiel
Tuynman, Jurriaan
Sietses, Colin
Postma, Maarten
Hompes, Roel
Consten, Esther
Smits, Anke
A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres
title A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres
title_full A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres
title_fullStr A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres
title_full_unstemmed A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres
title_short A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres
title_sort cost overview of minimally invasive total mesorectal excision in rectal cancer patients: a population-based cohort in experienced centres
topic Original Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431334/
https://www.ncbi.nlm.nih.gov/pubmed/37600875
http://dx.doi.org/10.1097/AS9.0000000000000263
work_keys_str_mv AT smalbroekbo acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT geitenbeekritchie acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT burghgraefthijs acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT dijksmanlea acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT holjeroen acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT rutgersmarieke acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT crollarogier acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT vangelovennanette acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT leijtensjeroen acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT polatfatih acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT pronkapollo acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT verdaasdonkemiel acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT tuynmanjurriaan acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT sietsescolin acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT postmamaarten acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT hompesroel acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT constenesther acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT smitsanke acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT smalbroekbo costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT geitenbeekritchie costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT burghgraefthijs costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT dijksmanlea costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT holjeroen costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT rutgersmarieke costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT crollarogier costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT vangelovennanette costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT leijtensjeroen costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT polatfatih costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT pronkapollo costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT verdaasdonkemiel costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT tuynmanjurriaan costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT sietsescolin costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT postmamaarten costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT hompesroel costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT constenesther costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres
AT smitsanke costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres